Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B, Asadzadeh Z, Motafakker Azad R, Mokhtarzadeh A, Baghbanzadeh A, Alemohammad H, Abdoli Shadbad M, Vasefifar P, Najafi S, Baradaran B. Najafzadeh B, et al. J Cell Physiol. 2021 Apr;236(4):2443-2458. doi: 10.1002/jcp.30063. Epub 2020 Sep 22. J Cell Physiol. 2021. PMID: 32960465 Review.
Nanog, as a key cancer stem cell marker in tumor progression.
Vasefifar P, Motafakkerazad R, Maleki LA, Najafi S, Ghrobaninezhad F, Najafzadeh B, Alemohammad H, Amini M, Baghbanzadeh A, Baradaran B. Vasefifar P, et al. Among authors: najafzadeh b. Gene. 2022 Jun 15;827:146448. doi: 10.1016/j.gene.2022.146448. Epub 2022 Mar 22. Gene. 2022. PMID: 35337852 Review.
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer.
Alemohammad H, Najafzadeh B, Asadzadeh Z, Baghbanzadeh A, Ghorbaninezhad F, Najafzadeh A, Safarpour H, Bernardini R, Brunetti O, Sonnessa M, Fasano R, Silvestris N, Baradaran B. Alemohammad H, et al. Among authors: najafzadeh b. Biomed Pharmacother. 2022 Feb;146:112516. doi: 10.1016/j.biopha.2021.112516. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906767 Free article. Review.
Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?
Ghorbaninezhad F, Alemohammad H, Najafzadeh B, Masoumi J, Shadbad MA, Shahpouri M, Saeedi H, Rahbarfarzam O, Baradaran B. Ghorbaninezhad F, et al. Among authors: najafzadeh b. Cancer Lett. 2023 May 28;562:216168. doi: 10.1016/j.canlet.2023.216168. Epub 2023 Apr 7. Cancer Lett. 2023. PMID: 37031915 Review.